To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ATP5C1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
349 representative clones for gene ATP5C1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX342796   .a 1 to 1103 5 to 1090 exact tiling clone,   1090/1090
(100 %)
11 diff
(99.0 %id)
BX384776   .a 2 to 1024 1 to 1011 L10A S11V A12G W13L T14D ...     1011/1020
(99 %)
10 diff
(99.1 %id)
BX383378   .a 6 to 284 1 to 278   fully sequenced,   278/278
(100 %)
2 diff
(99.3 %id)
BM544757 brain, hippocampus .a 12 to 963 1 to 951 Y229L Q230P E231R Y232I N233Q ...     951/1058
(89 %)
10 diff
(99.1 %id)
BQ420501 embryonal carcinoma, cell line, testis .a 16 to 958 1 to 940 L273*     940/1036
(90 %)
10 diff
(99.1 %id)
BX346696 Placenta Cot 25-normalized .a 19 to 1022 1 to 997 S245X K262E tiling clone,   997/997
(100 %)
5 diff
(99.5 %id)
BE379995 bladder, carcinoma, cell line .a 21 to 543 1 to 524   fully sequenced,   524/524
(100 %)
0 diff
(100 %id)
BM905295 melanotic melanoma, skin .a 22 to 963 36 to 986 A260G T274N F275I N276H T278Y ...     948/1022
(92 %)
26 diff
(97.5 %id)
BM478228 lymph, lymphoma, cell line .a 38 to 1065 1 to 1026       1026/1038
(98 %)
16 diff
(98.5 %id)
BX395055 Neuroblastoma Cot 25-normalized .a 41 to 1105 1 to 1046   tiling clone, fully sequenced,   1046/1046
(100 %)
9 diff
(99.2 %id)
BM907194 large cell carcinoma, lung .a 51 to 963 1 to 920       920/1000
(92 %)
16 diff
(98.4 %id)
BM468608 leiomyosarcoma, uterus .a 185 to 1097 1 to 910   tiling clone,   910/1087
(83 %)
8 diff
(99.3 %id)
BX383377   .a 223 to 1086 860 to 1   tiling clone, fully sequenced,   860/860
(100 %)
10 diff
(98.9 %id)
BE379575 bladder, carcinoma, cell line .a 513 to 1044 528 to 1   tiling clone, fully sequenced,   528/528
(100 %)
10 diff
(98.2 %id)
BX395054 Neuroblastoma Cot 25-normalized .a 637 to 998 357 to 1   fully sequenced,   357/357
(100 %)
6 diff
(98.4 %id)
BE176906 head_neck .a 699 to 963 301 to 27     Submitted on the opposite strand 283/301
(94 %)
56 diff
(81.4 %id)
CB144767 Liver .b 1 to 349 1 to 350   tiling clone,   350/350
(100 %)
2 diff
(99.5 %id)
BQ893894 brain, neuroblastoma, cell line .b 26 to 953 1 to 930       930/930
(100 %)
11 diff
(98.9 %id)
CF126485 Chondrosarcoma Lung Metastasis cell lines, lung .b 27 to 699 1 to 673       673/673
(100 %)
0 diff
(100 %id)
NM_001001973.1   .b 27 to 1165 1 to 1139 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1139/1139
(100 %)
0 diff
(100 %id)
TI_154189479   .b 27 to 966 50 to 974   tiling clone,   927/994
(93 %)
22 diff
(97.8 %id)
BU656897 blood .b 51 to 546 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BC000931 Placenta, choriocarcinoma .b 53 to 1165 1 to 1113 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1113/1113
(100 %)
1 diff
(100.0 %id)
DB448104 testis .b 54 to 486 1 to 433       433/433
(100 %)
0 diff
(100 %id)
DB483762 hippocampus .b 56 to 504 1 to 449       449/449
(100 %)
2 diff
(99.6 %id)
BP261250 small intestine .b 56 to 637 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CB160195 Liver .b 59 to 575 1 to 517       517/517
(100 %)
0 diff
(100 %id)
DB215989 trachea .b 59 to 601 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BM848726 stomach .b 60 to 641 1 to 582       582/582
(100 %)
0 diff
(100 %id)
FN082341 breast carcinoma .b 63 to 121 59 to 1     Submitted on the opposite strand 59/60
(98 %)
0 diff
(100 %id)
BC020824 Liver .b 65 to 1168 1 to 1104 exact available from MGC, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1104/1106
(99 %)
2 diff
(99.9 %id)
BU657633 blood .b 65 to 592 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BP283565 bone marrow .b 65 to 651 1 to 587       587/587
(100 %)
0 diff
(100 %id)
AV717093   .b 66 to 783 1 to 717       717/717
(100 %)
4 diff
(99.5 %id)
FN164212 breast carcinoma .b 66 to 132 1 to 67       67/67
(100 %)
0 diff
(100 %id)
AA155926   .b 68 to 632 1 to 557   fully sequenced,   557/557
(100 %)
5 diff
(99.2 %id)
CR612179 B cells (Ramos cell line) Cot 25-normalized .b 71 to 1174 1 to 1104 exact     1104/1104
(100 %)
0 diff
(100 %id)
BX391487   .b 71 to 1103 1 to 1023 E78X K79X A80X D81G P85A ... AAA   1026/1067
(96 %)
23 diff
(97.9 %id)
CN289733 embryonic stem cells, DMSO-treated H9 cellline .b 72 to 386 1 to 315       315/315
(100 %)
0 diff
(100 %id)
BP419078 small intestine .b 72 to 551 1 to 480     Submitted on the opposite strand 480/480
(100 %)
0 diff
(100 %id)
BU069569 insulinoma, Pancreas .b 72 to 499 1 to 428   fully sequenced, Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 428/428
(100 %)
3 diff
(99.3 %id)
AV682152 hepatocellular carcinoma .b 73 to 702 1 to 630       630/630
(100 %)
2 diff
(99.7 %id)
BC016812 Bladder, carcinoma .b 74 to 1168 4 to 1098 T45A available from MGC, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1095/1097
(99 %)
3 diff
(99.8 %id)
D16562 Liver .b 74 to 1188 1 to 1115 exact tiling clone,   1115/1115
(100 %)
0 diff
(100 %id)
BP263712 small intestine .b 74 to 653 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BM818445 Ascites, stomach .b 74 to 674 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BM764939 Ascites, stomach .b 74 to 781 1 to 708       708/708
(100 %)
0 diff
(100 %id)
BM773140 Ascites, stomach .b 74 to 609 1 to 536       536/536
(100 %)
0 diff
(100 %id)
BM773314 Ascites, stomach .b 74 to 665 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BM762124 myeloma .b 74 to 783 1 to 710       710/710
(100 %)
0 diff
(100 %id)
BM846551 myeloma .b 74 to 668 1 to 595       595/595
(100 %)
0 diff
(100 %id)
BM831805 stomach .b 74 to 451 1 to 378       378/378
(100 %)
0 diff
(100 %id)
BM831367 stomach .b 74 to 791 1 to 718       718/718
(100 %)
1 diff
(99.9 %id)
BP355642   .b 74 to 656 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA511763 brain .b 75 to 635 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB493173 hypothalamus .b 75 to 492 1 to 418       418/418
(100 %)
0 diff
(100 %id)
BP260705 small intestine .b 75 to 656 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB105596 thymus .b 75 to 623 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB132528 thymus .b 75 to 612 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB224713 trachea .b 75 to 634 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CR611688 B cells (Ramos cell line) Cot 25-normalized .b 76 to 1141 1 to 1066 exact     1066/1066
(100 %)
0 diff
(100 %id)
BC010380 Bladder, carcinoma .b 76 to 1168 5 to 1095 L93P I94W G95C S97L S98R ... available from MGC, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1091/1093
(99 %)
4 diff
(99.7 %id)
BP312782 mammary gland .b 76 to 658 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP373317 umbilical cord .b 76 to 656 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP264783 muscle .b 77 to 845 1 to 775       775/781
(99 %)
14 diff
(98.3 %id)
BG941515 blood .b 79 to 447 1 to 369       369/369
(100 %)
9 diff
(97.6 %id)
DA893096 skeletal muscle .b 79 to 655 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BP216294 corpus callosum .b 80 to 662 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CD238776 Pituitary .b 81 to 810 1 to 730       730/732
(99 %)
1 diff
(99.9 %id)
AV715792   .b 81 to 783 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
AV708508 adrenal gland .b 83 to 509 1 to 427       427/427
(100 %)
0 diff
(100 %id)
BM786402 Ascites, stomach .b 83 to 775 1 to 693       693/693
(100 %)
0 diff
(100 %id)
T32178 brain .b 83 to 458 1 to 375       375/375
(100 %)
6 diff
(98.4 %id)
BF106424 lung .b 84 to 595 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BC000470 Muscle, rhabdomyosarcoma .b 86 to 1165 1 to 1080 exact available from MGC, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1080/1080
(100 %)
1 diff
(100.0 %id)
BC013394 Muscle, rhabdomyosarcoma .b 86 to 1165 1 to 1080   available from MGC, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1080/1080
(100 %)
1 diff
(100.0 %id)
EB388671 eye, optic nerve .b 86 to 949 1 to 864       864/864
(100 %)
2 diff
(99.8 %id)
AV716150   .b 87 to 702 1 to 616       616/616
(100 %)
0 diff
(100 %id)
BU588062 mixed (pool of 40 RNAs) .b 87 to 450 1 to 364   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 364/386
(94 %)
7 diff
(98.2 %id)
CX759526 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 87 to 777 1 to 691       691/691
(100 %)
0 diff
(100 %id)
ES312921 beard hair, skin .b 88 to 243 1 to 156       156/156
(100 %)
0 diff
(100 %id)
BC013865 Skin, melanotic melanoma. .b 88 to 1165 1 to 1078 exact available from MGC, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1078/1078
(100 %)
0 diff
(100 %id)
BQ072153 brain, neuroblastoma, cell line .b 88 to 982 1 to 901       901/1028
(87 %)
18 diff
(98.3 %id)
BQ439942 embryonal carcinoma, cell line, testis .b 88 to 979 1 to 905       902/906
(99 %)
27 diff
(97.1 %id)
BU193371 eye, retinoblastoma .b 88 to 953 1 to 873       873/877
(99 %)
9 diff
(99.0 %id)
CN289740 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 89 to 701 1 to 613       613/613
(100 %)
0 diff
(100 %id)
BE787362 large cell carcinoma, lung .b 89 to 811 1 to 725       725/769
(94 %)
13 diff
(98.4 %id)
BG389606 embryonal carcinoma, cell line, testis .b 89 to 877 1 to 786       786/787
(99 %)
6 diff
(99.3 %id)
CF126916 Chondrosarcoma Lung Metastasis cell lines, lung .b 89 to 784 1 to 696       696/696
(100 %)
0 diff
(100 %id)
BQ050074 lymph, lymphoma, cell line .b 90 to 982 1 to 900       900/968
(92 %)
11 diff
(98.9 %id)
BQ897518 dorsal root ganglia .b 90 to 948 1 to 867       867/867
(100 %)
11 diff
(98.8 %id)
BQ962663 leiomyosarcoma, uterus .b 90 to 897 1 to 813       813/913
(89 %)
8 diff
(99.2 %id)
CD620013   .b 92 to 656 1 to 565       565/565
(100 %)
0 diff
(100 %id)
CR595574 Placenta Cot 25-normalized .b 93 to 1174 1 to 1082 exact     1082/1082
(100 %)
0 diff
(100 %id)
CN289738 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 95 to 830 1 to 736       736/736
(100 %)
0 diff
(100 %id)
BE865553 bladder, carcinoma, cell line .b 95 to 427 1 to 333       333/333
(100 %)
0 diff
(100 %id)
BM460299 eye, retinoblastoma .b 96 to 1003 37 to 942       906/1109
(81 %)
20 diff
(98.2 %id)
BM832056 stomach .b 96 to 362 1 to 267       267/267
(100 %)
0 diff
(100 %id)
BM906997 brain, hippocampus .b 97 to 1003 13 to 928       916/1069
(85 %)
30 diff
(97.2 %id)
BU193572 melanotic melanoma, skin .b 97 to 884 1 to 791       791/885
(89 %)
13 diff
(98.6 %id)
CB132875 Liver .b 98 to 648 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BM832154 stomach .b 98 to 446 1 to 349       349/349
(100 %)
0 diff
(100 %id)
CD694578 normal nasopharynx .b 99 to 714 1 to 616       616/616
(100 %)
0 diff
(100 %id)
BP425856 small intestine .b 99 to 257 1 to 159     Submitted on the opposite strand 159/159
(100 %)
0 diff
(100 %id)
BM906932 brain, hippocampus .b 99 to 1003 1 to 916       915/1068
(85 %)
35 diff
(96.8 %id)
DA729059   .b 99 to 772 2 to 677   fully sequenced, capped   676/676
(100 %)
0 diff
(100 %id)
CN289724 embryonic stem cells, DMSO-treated H9 cellline .b 100 to 791 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
CR616512 Neuroblastoma Cot 50-normalized .b 100 to 1157 1 to 1058 exact     1058/1058
(100 %)
0 diff
(100 %id)
BI089608 cervix .b 103 to 902 1 to 807       807/1122
(71 %)
14 diff
(98.8 %id)
CN289734 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 104 to 665 1 to 562       562/562
(100 %)
0 diff
(100 %id)
TI_1948242794   .b 104 to 1001 136 to 1037       902/1382
(65 %)
33 diff
(97.7 %id)
TI_1948243079   .b 104 to 998 130 to 1031       902/1370
(65 %)
30 diff
(97.9 %id)
TI_1948243368   .b 104 to 1002 135 to 1033       899/1401
(64 %)
35 diff
(97.6 %id)
CR457403   .b 105 to 1001 1 to 897 exact     897/897
(100 %)
0 diff
(100 %id)
CV023860 mixed .b 105 to 772 1 to 668       668/668
(100 %)
0 diff
(100 %id)
BF219971 muscle, rhabdomyosarcoma .b 105 to 741 1 to 635       635/650
(97 %)
3 diff
(99.6 %id)
BG680665 skin, squamous cell carcinoma .b 107 to 902 1 to 800       800/1020
(78 %)
7 diff
(99.4 %id)
BE886970 leiomyosarcoma, uterus .b 108 to 884 1 to 777       777/939
(82 %)
14 diff
(98.6 %id)
BE887870 leiomyosarcoma, uterus .b 108 to 896 1 to 810       753/950
(79 %)
39 diff
(95.9 %id)
BG575928 breast, mammary adenocarcinoma, cell line .b 108 to 902 1 to 798       798/810
(98 %)
8 diff
(99.1 %id)
BU556821 ovary, teratocarcinoma, cell line .b 108 to 998 1 to 900       900/946
(95 %)
19 diff
(98.0 %id)
CA849140 Pancreas, Purified pancreatic islet .b 109 to 563 1 to 455   fully sequenced,   455/455
(100 %)
2 diff
(99.6 %id)
CN289731 embryonic stem cells, DMSO-treated H9 cellline .b 112 to 773 1 to 662       662/662
(100 %)
0 diff
(100 %id)
CN289741 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 112 to 553 1 to 442       442/442
(100 %)
0 diff
(100 %id)
BM449626 leiomyosarcoma, uterus .b 112 to 1028 1 to 922       922/1024
(90 %)
6 diff
(99.5 %id)
BE536418 cervix .b 113 to 677 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BF724414 eye, Iris .b 114 to 600 1 to 487       487/487
(100 %)
0 diff
(100 %id)
BG676088 skin, squamous cell carcinoma .b 114 to 940 1 to 826       826/826
(100 %)
1 diff
(99.9 %id)
BM712164 eye, lens .b 114 to 563 1 to 450   fully sequenced, Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 450/450
(100 %)
0 diff
(100 %id)
CR621366 Neuroblastoma Cot 25-normalized .b 115 to 1174 1 to 1060       1060/1060
(100 %)
0 diff
(100 %id)
AV661213 corresponding non cancerous liver tissue .b 117 to 509 1 to 393     Submitted on the opposite strand 393/393
(100 %)
0 diff
(100 %id)
CA454345   .b 117 to 741 1 to 626       626/641
(97 %)
2 diff
(99.7 %id)
CA943209 Pancreas, Purified pancreatic islet .b 119 to 587 1 to 469       469/469
(100 %)
0 diff
(100 %id)
CA943076 Pancreas, Purified pancreatic islet .b 119 to 589 1 to 471       471/471
(100 %)
0 diff
(100 %id)
CA848743 Pancreas, Purified pancreatic islet .b 119 to 695 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BU618395 Cell Line, Chondrosarcoma .b 122 to 519 305 to 699   AAA Submitted on the opposite strand 395/686
(57 %)
8 diff
(98.9 %id)
CN484048 eye .b 125 to 777 1 to 653       653/653
(100 %)
0 diff
(100 %id)
CB120293 Liver .b 125 to 639 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BG116627 duodenal adenocarcinoma, cell line, small intestine .b 126 to 896 1 to 770       770/890
(86 %)
14 diff
(98.5 %id)
BC026049 Pancreas, epithelioid carcinoma .b 126 to 1165 1 to 1040   available from MGC, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1040/1040
(100 %)
0 diff
(100 %id)
BE888001 leiomyosarcoma, uterus .b 132 to 897 1 to 768       768/909
(84 %)
20 diff
(97.8 %id)
BY800272 eye .b 136 to 608 1 to 473       473/473
(100 %)
0 diff
(100 %id)
BE896087 melanotic melanoma, skin .b 145 to 831 1 to 686       686/687
(99 %)
2 diff
(99.8 %id)
BF725763 eye, Iris .b 149 to 563 1 to 415       415/415
(100 %)
0 diff
(100 %id)
BM312031 Pancreas, Purified pancreatic islet .b 160 to 719 7 to 566       560/566
(98 %)
6 diff
(99.0 %id)
CN289739 embryonic stem cells, DMSO-treated H9 cellline .b 166 to 581 1 to 416       416/416
(100 %)
0 diff
(100 %id)
BM876134 insulinoma, Pancreas .b 172 to 701 1 to 530     Submitted on the opposite strand 530/530
(100 %)
0 diff
(100 %id)
CN289723 embryonic stem cells, cell lines H1, H7, andH9 .b 209 to 397 1 to 189       189/189
(100 %)
0 diff
(100 %id)
AA171958   .b 229 to 637 1 to 409       409/409
(100 %)
2 diff
(99.6 %id)
AA781343   .b 249 to 1173 921 to 1       922/930
(99 %)
38 diff
(96.0 %id)
BG674627 skin .b 259 to 995 1 to 738       738/745
(99 %)
3 diff
(99.6 %id)
CK430143 eye, lacrimal gland .b 259 to 873 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BF980814 duodenal adenocarcinoma, cell line, small intestine .b 263 to 990 1 to 733       730/928
(78 %)
12 diff
(98.8 %id)
U46324 liver cell line, pancreatic cancer .b 278 to 557 1 to 280       280/280
(100 %)
0 diff
(100 %id)
AA303584 aorta .b 297 to 443 1 to 147       147/147
(100 %)
0 diff
(100 %id)
FN096228 breast carcinoma .b 323 to 390 68 to 1     Submitted on the opposite strand 68/69
(98 %)
2 diff
(97.2 %id)
TI_227712433   .b 326 to 1170 915 to 79   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 837/1006
(83 %)
16 diff
(98.5 %id)
BM762271 myeloma .b 349 to 977 1 to 629       629/629
(100 %)
0 diff
(100 %id)
CB219094 mandible, pooled .b 356 to 940 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BM824743 Ascites, stomach .b 356 to 827 1 to 472       472/472
(100 %)
0 diff
(100 %id)
BM762231 myeloma .b 359 to 827 1 to 469       469/469
(100 %)
0 diff
(100 %id)
BM841966 myeloma .b 359 to 1022 1 to 664       664/664
(100 %)
0 diff
(100 %id)
AA298153 Bone .b 361 to 606 1 to 246       246/246
(100 %)
0 diff
(100 %id)
AA298154 Bone .b 361 to 619 1 to 259       259/259
(100 %)
0 diff
(100 %id)
TI_149308314   .b 411 to 1170 841 to 84   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 758/984
(77 %)
10 diff
(99.0 %id)
BQ008441 Chondrosarcoma, Left Pubic Bone .b 438 to 1170 743 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 730/730
(100 %)
4 diff
(99.5 %id)
AA385385 thyroid gland .b 446 to 726 1 to 281       281/281
(100 %)
0 diff
(100 %id)
CA432708 cell lines, Chondrosarcoma .b 468 to 1170 720 to 19   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 702/702
(100 %)
1 diff
(99.9 %id)
BU622511 cell lines, Chondrosarcoma .b 469 to 1170 718 to 19   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 700/700
(100 %)
3 diff
(99.6 %id)
BE073290 breast .b 471 to 758 288 to 1     Submitted on the opposite strand 288/288
(100 %)
0 diff
(100 %id)
TI_149301108   .b 485 to 1170 753 to 68   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 686/687
(99 %)
0 diff
(100 %id)
BU616673 Bone, Subchondral Bone .b 488 to 1170 701 to 19   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 683/684
(99 %)
2 diff
(99.8 %id)
CA429254 Cell Line, Chondrosarcoma .b 491 to 1170 692 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 679/679
(100 %)
1 diff
(99.9 %id)
BU069363 insulinoma, Pancreas .b 492 to 1170 695 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 679/679
(100 %)
1 diff
(99.9 %id)
BM670227 eye, lens .b 503 to 1170 682 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 669/669
(100 %)
1 diff
(99.9 %id)
BM977052 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 505 to 1170 679 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 666/666
(100 %)
0 diff
(100 %id)
CD367139 Alveolar Macrophage, lung .b 508 to 1170 676 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 663/663
(100 %)
0 diff
(100 %id)
CA848835 Pancreas, Purified pancreatic islet .b 520 to 1169 651 to 3   fully sequenced,   649/651
(99 %)
1 diff
(99.9 %id)
BM803906 leiomyosarcoma, uterus .b 522 to 1189 1 to 668       668/673
(99 %)
2 diff
(99.8 %id)
BM314947 Pancreas, Purified pancreatic islet .b 529 to 1170 641 to 1       641/648
(98 %)
1 diff
(99.9 %id)
EC491591 Prostate .b 539 to 643 101 to 1       101/101
(100 %)
4 diff
(96.1 %id)
CR619950 Placenta Cot 25-normalized .b 557 to 1174 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BQ926438 sciatic nerve .b 557 to 1170 1 to 614   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
BU687163 lung, Primary Lung Epithelial Cells .b 565 to 1170 619 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 606/606
(100 %)
0 diff
(100 %id)
BM768452 stomach .b 577 to 1151 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BQ083293 stomach .b 577 to 999 1 to 423       423/423
(100 %)
0 diff
(100 %id)
BI676498 Pancreas, Purified pancreatic islet .b 582 to 1169 588 to 1       588/588
(100 %)
0 diff
(100 %id)
BI676499 Pancreas, Purified pancreatic islet .b 594 to 1169 576 to 1       576/576
(100 %)
0 diff
(100 %id)
AA155823   .b 602 to 1174 566 to 2   fully sequenced,   565/566
(99 %)
7 diff
(98.8 %id)
BU186549 epithelioid carcinoma, Pancreas .b 608 to 1170 1 to 563   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 563/563
(100 %)
0 diff
(100 %id)
BI899560 Pancreas, Purified pancreatic islet .b 642 to 1169 528 to 1       528/528
(100 %)
0 diff
(100 %id)
CB132718 Liver .b 652 to 1165 1 to 514       514/514
(100 %)
0 diff
(100 %id)
BU752263 placenta .b 669 to 1170 514 to 13   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 502/502
(100 %)
0 diff
(100 %id)
BP391145 pancreatic islet .b 672 to 1171 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AA550846 adrenal adenoma, adrenal gland .b 722 to 999 278 to 1       278/278
(100 %)
0 diff
(100 %id)
CA842799 Pancreas, Purified pancreatic islet .b 723 to 1174 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AA171745   .b 736 to 1171 436 to 1       436/436
(100 %)
0 diff
(100 %id)
DB354096   .b 741 to 1170 430 to 1   fully sequenced,   430/430
(100 %)
2 diff
(99.6 %id)
BM768471 stomach .b 756 to 1171 1 to 416       416/416
(100 %)
0 diff
(100 %id)
AA432298   .b 759 to 1150 1 to 392   fully sequenced,   392/392
(100 %)
0 diff
(100 %id)
AW606552 head_neck .b 773 to 902 134 to 5       130/134
(97 %)
0 diff
(100 %id)
AW609982 stomach .b 773 to 902 144 to 13       132/144
(91 %)
0 diff
(100 %id)
BE909101 epithelioid carcinoma, Pancreas .b 781 to 1170 1 to 390   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 390/390
(100 %)
0 diff
(100 %id)
AA554297 colon .b 837 to 1170 334 to 1       334/334
(100 %)
0 diff
(100 %id)
BE536536 cervix .b 929 to 1174 1 to 246       246/246
(100 %)
0 diff
(100 %id)
FN154507 breast carcinoma .b 933 to 1020 1 to 88       88/88
(100 %)
0 diff
(100 %id)
AA877096 Kidney .b 943 to 1169 227 to 1       227/227
(100 %)
0 diff
(100 %id)
AA428639   .b 964 to 1170 207 to 1   fully sequenced,   207/207
(100 %)
0 diff
(100 %id)
CA944456 Human Lung Epithelial cells, lung .b 1037 to 1170 147 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 134/134
(100 %)
0 diff
(100 %id)
EC456073 Prostate .b 1048 to 1158 1 to 111       111/111
(100 %)
0 diff
(100 %id)
EC528667 Prostate .b 1048 to 1159 112 to 2       111/115
(96 %)
0 diff
(100 %id)
EC440950 Prostate .b 1050 to 1162 118 to 5       114/118
(96 %)
0 diff
(100 %id)
AK292896 trachea .c 1 to 941 2 to 942 exact tiling clone,   942/942
(100 %)
0 diff
(100 %id)
NM_005174.2   .d 1 to 1102 1 to 1102 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 1102/1102
(100 %)
0 diff
(100 %id)
D16563 heart .d 48 to 1125 1 to 1078 exact tiling clone,   1078/1078
(100 %)
0 diff
(100 %id)
AK129907 heart .d 49 to 1107 376 to 1434 exact available from FLJ,   1059/1434
(73 %)
6 diff
(99.6 %id)
BG751390 eye, normal pigmented retinal epithelium .d 73 to 999 1 to 931 E244G S245V T246H T247H S248*     931/931
(100 %)
16 diff
(98.3 %id)
TI_227713823   .d 259 to 1107 928 to 89   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 840/967
(86 %)
13 diff
(98.7 %id)
TI_149294804   .d 288 to 1107 897 to 85   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 813/965
(84 %)
17 diff
(98.3 %id)
TI_154027606   .d 304 to 1107 875 to 79   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 797/804
(99 %)
19 diff
(97.7 %id)
CR606908 Neuroblastoma Cot 50-normalized .d 311 to 1111 1 to 801       801/801
(100 %)
0 diff
(100 %id)
TI_149290187   .d 312 to 1107 867 to 80   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 788/790
(99 %)
11 diff
(98.7 %id)
BM697963 eye, fetal eyes .d 345 to 746 1 to 402   fully sequenced, Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 402/402
(100 %)
0 diff
(100 %id)
TI_154061925   .d 349 to 1107 850 to 96   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 755/983
(76 %)
5 diff
(99.5 %id)
BU683431 lung .d 367 to 1107 752 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 739/739
(100 %)
2 diff
(99.8 %id)
BU624741 cell lines, Enchondroma .d 383 to 1107 740 to 19   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 722/722
(100 %)
3 diff
(99.6 %id)
BQ771736 Chondrosarcoma Grade II, Left Pelvis .d 389 to 1107 737 to 19   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 719/723
(99 %)
0 diff
(100 %id)
BQ028041 mixed .d 426 to 1107 695 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 682/682
(100 %)
0 diff
(100 %id)
CA420872 Bone, Enchondroma cell line .d 457 to 1107 669 to 19   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 651/651
(100 %)
0 diff
(100 %id)
CA442020 lung, Metastatic Chondrosarcoma .d 480 to 1107 641 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 628/628
(100 %)
0 diff
(100 %id)
BM973210 lung .d 489 to 1107 632 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 619/619
(100 %)
0 diff
(100 %id)
BQ005822 Chondrosarcoma, Left Pubic Bone .d 530 to 1107 591 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 578/578
(100 %)
0 diff
(100 %id)
BG462054   .d 552 to 1093 541 to 1     Submitted on the opposite strand 541/541
(100 %)
5 diff
(99.1 %id)
AA593335 Kidney, kidney tumor .d 601 to 1106 506 to 1       506/506
(100 %)
0 diff
(100 %id)
AA593315 Kidney, kidney tumor .d 603 to 1107 505 to 1       505/505
(100 %)
0 diff
(100 %id)
AJ706829 heart .d 678 to 1107 429 to 1     Submitted on the opposite strand 429/429
(100 %)
1 diff
(99.8 %id)
BM667127 eye, fetal eyes .d 685 to 1105 441 to 21   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 421/423
(99 %)
0 diff
(100 %id)
AA032044 uterus .d 696 to 1111 1 to 417   fully sequenced,   417/417
(100 %)
3 diff
(99.3 %id)
BQ350519 head_neck .d 734 to 1028 298 to 4       295/311
(94 %)
3 diff
(99.1 %id)
BQ350520 head_neck .d 734 to 1031 297 to 1       297/310
(95 %)
4 diff
(98.8 %id)
BQ350522 head_neck .d 734 to 1018 295 to 10       286/308
(92 %)
11 diff
(96.5 %id)
BQ350524 head_neck .d 734 to 1015 289 to 10       280/303
(92 %)
1 diff
(99.7 %id)
BQ350527 head_neck .d 734 to 1030 296 to 1       296/309
(95 %)
5 diff
(98.4 %id)
BQ350581 head_neck .d 735 to 1046 313 to 3       311/340
(91 %)
16 diff
(95.3 %id)
F32443 pectoral muscle (after mastectomy) .d 763 to 1107 1 to 345       345/345
(100 %)
0 diff
(100 %id)
BQ350521 head_neck .d 771 to 1018 253 to 4       250/253
(98 %)
7 diff
(97.3 %id)
FN165065 breast carcinoma .d 898 to 999 1 to 102       102/104
(98 %)
5 diff
(95.2 %id)
AA031962 uterus .d 905 to 1107 203 to 1   fully sequenced,   203/203
(100 %)
0 diff
(100 %id)
CB987196 Pooled-Glandular .e 1 to 643 1 to 645   tiling clone,   645/776
(83 %)
10 diff
(98.8 %id)
CA313108 Human Lung Epithelial cells, lung .e 598 to 1039 455 to 14   tiling clone, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 442/442
(100 %)
0 diff
(100 %id)
BM541513 leiomyosarcoma, uterus .f 1 to 870 1 to 866 exact tiling clone,   1012/1040
(97 %)
10 diff
(99.1 %id)
BG942275 blood .f 627 to 870 405 to 167   tiling clone,   382/405
(94 %)
3 diff
(99.3 %id)
TI_45210324   .g 1 to 774 90 to 864       775/864
(89 %)
10 diff
(98.9 %id)
DB506490 hypothalamus .g 4 to 474 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
BI603806 brain, hypothalamus .g 4 to 774 6 to 776   tiling clone,   771/776
(99 %)
10 diff
(98.8 %id)
DA402112 thalamus .g 20 to 584 2 to 566   capped   565/566
(99 %)
2 diff
(99.7 %id)
BG506800 lung .g 27 to 783 1 to 757       757/758
(99 %)
23 diff
(97.0 %id)
DB140192 thymus .g 29 to 566 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BP216539 corpus callosum .g 33 to 614 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
AK296803 tongue, tumor tissue .g 37 to 943 1 to 907 exact tiling clone,   907/907
(100 %)
0 diff
(100 %id)
DA444132 tongue, tumor tissue .g 38 to 618 2 to 582   capped   581/582
(99 %)
1 diff
(99.9 %id)
DA313901 hippocampus .g 40 to 587 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
CN289736 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 41 to 836 12 to 807       796/807
(98 %)
7 diff
(99.2 %id)
BG496408 lung, mucoepidermoid carcinoma .g 41 to 415 1 to 376       376/377
(99 %)
4 diff
(99.0 %id)
BU186645 large cell carcinoma, lung .g 51 to 603 12 to 567       556/981
(56 %)
27 diff
(97.3 %id)
AV748435 Pituitary .g 62 to 627 1 to 560       563/567
(99 %)
11 diff
(98.1 %id)
AV704706 adrenal gland .g 70 to 606 1 to 533       533/692
(77 %)
9 diff
(98.7 %id)
BE788673 large cell carcinoma, lung .g 74 to 814 1 to 735       735/899
(81 %)
21 diff
(97.7 %id)
BU956114 adenocarcinoma, cell line, breast .g 92 to 926 1 to 839 D211G N212H L224M T231N R232P ...     839/871
(96 %)
16 diff
(98.2 %id)
CD677976 eye, Trabecular meshwork .h 1 to 613 1 to 613   tiling clone,   613/613
(100 %)
0 diff
(100 %id)
BF794389 lymph, lymphoma, cell line .h 18 to 762 1 to 745   tiling clone,   745/918
(81 %)
13 diff
(98.6 %id)
TI_154193019   .i 1 to 693 50 to 740 K198X R207A Q208S A209C V210H tiling clone,   691/779
(88 %)
3 diff
(99.7 %id)
DA376655 thalamus .j 1 to 477 2 to 478 exact tiling clone, capped   477/477
(100 %)
0 diff
(100 %id)
DA413528 thalamus .j 1 to 557 2 to 559 N40S A53G A54S Y56I A57C ... capped   558/558
(100 %)
2 diff
(99.7 %id)
AK294061 cerebellum .j 2 to 906 1 to 905 exact tiling clone,   905/905
(100 %)
1 diff
(99.9 %id)
DA128875 cerebellum .j 3 to 597 2 to 596 exact capped   595/595
(100 %)
1 diff
(99.9 %id)
BM507285 insulinoma, Pancreas .j 26 to 518 1 to 493 exact     493/493
(100 %)
4 diff
(99.2 %id)
TI_57235386   .j 39 to 814 31 to 806   tiling clone,   776/806
(96 %)
8 diff
(99.1 %id)
BI909322 leukocyte .j 40 to 814 1 to 775       775/775
(100 %)
2 diff
(99.8 %id)
FN157370 breast carcinoma .j 543 to 676 134 to 1     Submitted on the opposite strand 134/134
(100 %)
3 diff
(97.8 %id)
BQ448448 Knee, Osteoarthritic Cartilage .k 1 to 456 469 to 14 L7X tiling clone, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 456/456
(100 %)
0 diff
(100 %id)
BU958209 mixed (pool of 40 RNAs) .l 1 to 290 3 to 292 exact tiling clone, AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 292/296
(98 %)
4 diff
(98.7 %id)
DA024344   .m-u 1 to 560 2 to 559   tiling clone, capped   558/558
(100 %)
3 diff
(99.5 %id)
DA734924   .m-u 517 to 1141 2 to 632   tiling clone, capped   631/633
(99 %)
11 diff
(98.3 %id)
BX505053   .m-u 560 to 1018 1 to 459   tiling clone,   459/459
(100 %)
2 diff
(99.6 %id)
DB271158 uterus .m-u 665 to 1232 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
CN289385 embryonic stem cells, DMSO-treated H9 cellline .m-u 798 to 1183 180 to 565       386/565
(68 %)
6 diff
(99.0 %id)
AA442715   .m-u 945 to 1442 1 to 498   tiling clone,   498/498
(100 %)
1 diff
(99.8 %id)
BF171919 blood .m-u 1003 to 1294 1 to 300       300/300
(100 %)
35 diff
(88.4 %id)
AA361722   .m-u 1096 to 1427 1 to 332   tiling clone,   332/332
(100 %)
0 diff
(100 %id)
DA083143 cerebellum .m-u 1337 to 1913 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DB289074 uterus .m-u 1378 to 1941 2 to 565   tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
BF873923 lung_tumor .m-u 1473 to 1678 206 to 1     Submitted on the opposite strand 206/206
(100 %)
1 diff
(99.6 %id)
CA391887 eye, RPE/choroid .m-u 1771 to 2388 1 to 618       618/618
(100 %)
2 diff
(99.7 %id)
BQ374334 prostate_tumor .m-u 1803 to 2205 1 to 403   tiling clone,   403/403
(100 %)
9 diff
(97.8 %id)
BE162154 head_neck .m-u 1966 to 2551 1 to 586       586/586
(100 %)
8 diff
(98.7 %id)
BG758389 B-cells, primary B-cells from tonsils (cell line) .m-u 1991 to 2834 1 to 846   tiling clone,   846/987
(85 %)
18 diff
(98.2 %id)
BX436791 thymus .m-u 2004 to 2785 792 to 1       792/792
(100 %)
17 diff
(97.9 %id)
DB367080   .m-u 2269 to 2813 539 to 1       539/541
(99 %)
14 diff
(97.5 %id)
DB295644   .m-u 2274 to 2813 540 to 1   tiling clone,   540/540
(100 %)
4 diff
(99.3 %id)
DB351990 uterus .m-u 2308 to 2813 506 to 1       506/506
(100 %)
2 diff
(99.7 %id)
BI038880 nervous_tumor .m-u 2320 to 2705 386 to 1       386/386
(100 %)
1 diff
(99.8 %id)
BI039128 nervous_tumor .m-u 2320 to 2719 413 to 16       398/413
(96 %)
0 diff
(100 %id)
AI539563 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m-u 2425 to 2823 399 to 1       399/402
(99 %)
4 diff
(99.1 %id)
AI537506 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m-u 2428 to 2829 401 to 1   tiling clone,   401/401
(100 %)
2 diff
(99.6 %id)
BI494955 cochlea, ear .m-u 2454 to 2813 8 to 367   fully sequenced, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 360/367
(98 %)
6 diff
(98.4 %id)
BI713058 Pancreas, Purified pancreatic islet .m-u 2557 to 2991 4 to 439 F27V K29X R36K N37K A38C ... fully sequenced,   436/439
(99 %)
7 diff
(98.5 %id)
BI494954 cochlea, ear .m-u 2615 to 2836 225 to 1   fully sequenced, Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 225/225
(100 %)
3 diff
(98.7 %id)
DB298001 cerebellum .m-u 2787 to 3318 532 to 1       532/532
(100 %)
2 diff
(99.7 %id)
AI581141 colon, moderately-differentiated adenocarcinoma .m-u 2796 to 3322 528 to 3   tiling clone,   526/528
(99 %)
0 diff
(100 %id)
BX118496 colon, moderately-differentiated adenocarcinoma .m-u 2852 to 3318 481 to 15   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 467/467
(100 %)
0 diff
(100 %id)
AA494437 colon .m-u 2867 to 3319 453 to 1       453/453
(100 %)
2 diff
(99.6 %id)
DA620704   .m-u 2896 to 3457 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
AW305124 brain, three pooled meningiomas .m-u 2925 to 3330 408 to 3       406/408
(99 %)
0 diff
(100 %id)
BI712105 Pancreas, Purified pancreatic islet .m-u 2961 to 3332 372 to 1   fully sequenced,   372/372
(100 %)
1 diff
(99.8 %id)
GD156799   .m-u 3265 to 3318 7 to 60   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 54/60
(90 %)
0 diff
(100 %id)
GD148023   .m-u 3266 to 3328 8 to 70       63/75
(84 %)
2 diff
(97.4 %id)
GD148161   .m-u 3266 to 3328 8 to 70       63/75
(84 %)
2 diff
(97.4 %id)
DA521498 brain .n 1 to 561 7 to 567 exact tiling clone, capped   566/566
(100 %)
3 diff
(99.5 %id)
BX480575   .n 234 to 686 7 to 459       453/459
(98 %)
6 diff
(98.7 %id)
DA531358 brain .n 277 to 788 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
BF760341 colon .n 298 to 630 344 to 13     Submitted on the opposite strand 332/344
(96 %)
0 diff
(100 %id)
DA554557   .n 408 to 988 2 to 582   tiling clone, capped   581/581
(100 %)
1 diff
(99.9 %id)
BI481316 Native Retinal Pigment Epithelium sheets, retina .n 801 to 1265 478 to 12   tiling clone, Submitted on the opposite strand 467/478
(97 %)
0 diff
(100 %id)
BF746275 breast .o-u 1 to 372 371 to 1   tiling clone, Submitted on the opposite strand 371/373
(99 %)
0 diff
(100 %id)
BF746345 breast .o-u 1 to 372 371 to 1     Submitted on the opposite strand 371/373
(99 %)
0 diff
(100 %id)
BF839647 head_neck .o-u 102 to 588 523 to 34   tiling clone, Submitted on the opposite strand 490/531
(92 %)
0 diff
(100 %id)
W05754 lung .o-u 142 to 687 1 to 549       549/549
(100 %)
6 diff
(99.0 %id)
BI439036 Pancreas, Purified pancreatic islet .o-u 191 to 729 11 to 549 exact tiling clone,   539/549
(98 %)
6 diff
(99.0 %id)
H59661 liver and spleen .o-u 235 to 836 1 to 596 L14R L20T C22L S23* fully sequenced,   596/596
(100 %)
22 diff
(96.4 %id)
W90087 liver and spleen .o-u 235 to 630 1 to 405       405/482
(84 %)
16 diff
(96.7 %id)
AW753258 colon .o-u 332 to 853 523 to 1 V6S A7S A8S N9Q S10F ...     523/523
(100 %)
5 diff
(99.1 %id)
N79402 multiple sclerosis lesions .o-u 334 to 490 1 to 158       158/160
(98 %)
4 diff
(97.5 %id)
N86573   .o-u 347 to 625 1 to 275       275/276
(99 %)
13 diff
(95.3 %id)
N55147 multiple sclerosis lesions .o-u 348 to 529 1 to 182       182/189
(96 %)
1 diff
(99.5 %id)
BG566752 Liver .o-u 517 to 1249 1 to 733 exact     733/745
(98 %)
17 diff
(97.8 %id)
BF921305 nervous_tumor .o-u 571 to 795 238 to 14     Submitted on the opposite strand 225/260
(86 %)
0 diff
(100 %id)
AW973444   .o-u 636 to 1245 610 to 1     Submitted on the opposite strand 610/610
(100 %)
3 diff
(99.6 %id)
BI438708 Pancreas, Purified pancreatic islet .o-u 690 to 1250 562 to 2   tiling clone,   561/562
(99 %)
0 diff
(100 %id)
BG232034 blood, lymphocyte .o-u 697 to 1245 549 to 1       549/549
(100 %)
0 diff
(100 %id)
AA563937 colon, tumor .o-u 755 to 1245 490 to 1       490/490
(100 %)
2 diff
(99.6 %id)
AI203964 lung .o-u 775 to 1246 485 to 14   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 472/472
(100 %)
0 diff
(100 %id)
AA426112   .o-u 787 to 1249 463 to 1       463/463
(100 %)
2 diff
(99.6 %id)
BQ346836 nervous_tumor .o-u 812 to 1154 370 to 22       349/370
(94 %)
0 diff
(100 %id)
H59619 liver and spleen .o-u 827 to 1241 420 to 1   fully sequenced,   420/420
(100 %)
11 diff
(97.4 %id)
N62501 multiple sclerosis lesions .o-u 846 to 1248 410 to 1       410/410
(100 %)
8 diff
(98.1 %id)
AI052801 liver and spleen .o-u 854 to 1246 393 to 1       393/393
(100 %)
2 diff
(99.5 %id)
AI092269 parathyroid gland, parathyroid tumor .o-u 894 to 1246 368 to 16   AAA Possibly primed on the genome, locally A rich (20/25 A in genome downstream of last aligned base) 353/353
(100 %)
1 diff
(99.8 %id)
R92614 liver and spleen .o-u 895 to 1240 351 to 1       351/351
(100 %)
6 diff
(98.3 %id)
N50791 multiple sclerosis lesions .o-u 899 to 1250 355 to 3       353/355
(99 %)
0 diff
(100 %id)
W90129 liver and spleen .o-u 904 to 1241 341 to 1       341/341
(100 %)
4 diff
(98.9 %id)
AI023994 liver and spleen .o-u 948 to 1241 294 to 1       294/294
(100 %)
1 diff
(99.7 %id)
AI824390 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .o-u 969 to 1248 282 to 1       282/282
(100 %)
4 diff
(98.6 %id)
AA016063 eye, retina .o-u 1010 to 1250 257 to 17     Submitted on the opposite strand 241/257
(93 %)
0 diff
(100 %id)
N75011 lung .o-u 1091 to 1246 156 to 1       156/156
(100 %)
0 diff
(100 %id)
BG545897 lung .p 1 to 572 3 to 576 exact tiling clone,   576/673
(85 %)
12 diff
(98.3 %id)
DA131070 alzheimer cortex .p 270 to 807 2 to 557   tiling clone, capped   556/556
(100 %)
8 diff
(98.6 %id)
CN264043 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .p 289 to 1003 1 to 716   tiling clone,   716/716
(100 %)
7 diff
(99.1 %id)
DB289992 uterus .q 1 to 586 2 to 587 exact tiling clone, capped   586/586
(100 %)
0 diff
(100 %id)
AA347959 heart .r-u 1 to 267 1 to 267 exact tiling clone,   267/267
(100 %)
0 diff
(100 %id)
EC527409 Prostate .s 1 to 118 1 to 118   tiling clone,   118/118
(100 %)
2 diff
(98.4 %id)
BG460013   .s 14 to 177 164 to 1 T9X K31R L33P tiling clone, Submitted on the opposite strand 164/164
(100 %)
2 diff
(98.8 %id)
BF334013 colon Gene ATP5C1, variant not shown              
BG459653   Gene ATP5C1, variant not shown         Submitted on the opposite strand    
BG459996   Gene ATP5C1, variant not shown         Submitted on the opposite strand    
BG460265   Gene ATP5C1, variant not shown         Submitted on the opposite strand    
BG460544   Gene ATP5C1, variant not shown         Submitted on the opposite strand    
BG460595   Gene ATP5C1, variant not shown         Submitted on the opposite strand    
BG460650   Gene ATP5C1, variant not shown         Submitted on the opposite strand    
BG460882   Gene ATP5C1, variant not shown         Submitted on the opposite strand    
BG461292   Gene ATP5C1, variant not shown         Submitted on the opposite strand    
BG461849   Gene ATP5C1, variant not shown         Submitted on the opposite strand    
F01740 brain, total brain Gene ATP5C1, variant not shown         This clone was ignored    
F05478 brain, total brain Gene ATP5C1, variant not shown         This clone was ignored    
342 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o-u, .p, .q, .r-u, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI